Abeona Therapeutics to Present at the 2017 RBC Capital Markets Global Healthcare Conference and 3rd Annual CRISPR Congress Feb 21, 2017
Abeona Therapeutics Provides Update from ABO-102 Phase 1/2 MPS IIIA Clinical Trial at the 13th Annual WORLDSymposium™ 2017 Feb 17, 2017
Abeona Therapeutics Announces Presentations and Posters at the 13th Annual WORLDSymposium™ 2017 Feb 7, 2017
Abeona Therapeutics Enrolls First High Dose Subject in Ongoing Phase 1/2 Gene Therapy Clinical Trial in Sanfilippo Syndrome Type A Feb 1, 2017
Abeona Therapeutics Receives Orphan Drug Designation in The European Union for ABO-101 Gene Therapy in Sanfilippo Syndrome Type B Jan 19, 2017
Abeona Therapeutics Receives Orphan Drug Designation in The European Union for ABO-201 Gene Therapy Program in Juvenile Batten Disease Jan 3, 2017
Abeona Therapeutics to Present at 2016 Genetic Rx Boston Biotech Conference at Harvard Medical School Dec 6, 2016
